Japan's Ministry of Health, Labor & Welfare (MHLW) and the country's evaluation agency, the Pharmaceuticals & Medical Devices Agency (PMDA), have been engaged in efforts through diplomatic channels such as the Global Harmonization Task Force (conceived in 1992 in an effort to achieve greater uniformity between national medical device regulatory systems including the United States, the European Union, Canada, Australia and Japan) and Harmonization By Doing (a bilateral effort between the United States and Japan).
The Global Harmonization Task Force (GHTF) examines the way countries around the world develop procedures, programs and regulations through the research of five study groups: premarket evaluation, post-market vigilance, quality systems, auditing and clinical safety and performance.
Jude, Guidant, and Others 12 Commercial Lasers (for Medical Use) 12 Potential Growth 12 Table 13: Global Commercial Laser (for Medical Use) Revenues by Type: Annual Market Estimates for 2003 through 2008 in Billions of US$ for Diode, and Nondiode Lasers 12 Table 14: Global Commercial Laser (for Medical Use) Revenues by Type: Percentage Market Share for 2004 and 2008 for Diode, and Nondiode 13 Regulations 13 Medical Device Regulations in the US 13 Medical Device Regulations in Europe 13 US and European Regulations: A Comparative Study 13 Global Harmonization Task Force Classification 14 Outlook 14 2.
While the FDA has sought to harmonize its regulations with those of foreign countries, particularly through the Global Harmonization Task Force, (23) the FDA inspection approach continues to differ from that used in foreign countries.
director of the Office of Science and Engineering Laboratories (OSEL) in FDA's Center for Devices, will chair the Global Harmonization Task Force (GHTF) for the next eighteen months.
Christine Nelson, director of international staff in the Division of Small Manufacturers, International and Consumer Assistance at the Center for Devices, focused on the process validation guidance of the Global Harmonization Task Force (GHTF) -- SG3.
Japan's Pharmaceutical Affairs Law (PAL) harmonizes the requirements of various international regulatory requirements and reduces the conflicting demands of these various regulations by incorporating the guidance documents of the Global Harmonization Task Force (GHTF).
